BETA: Please send your feedback!

ResMed

RMD:NYS

Medical Specialties

$0
LARGE cap
$156.24 (1.08%)
0.01%
since start of 2020
49.37
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • 5
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership
  • —
  • 1
  • 2
  • 3
  • 4
  • 5

About

ResMed, Inc. engages in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders including sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its product portfolio includes obstructive sleep apnea, and other respiratory disorders that occur during sleep. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
 website

Headquarters

9001 Spectrum Center Boulevard
San Diego, CA 92123
1.858.836.5000

Executives

Name Title Gender
David Pendarvis Secretary & Chief Administrative Officer Male
Brett A. Sandercock Chief Financial Officer Male
Rob Douglas, MBA President & Chief Operating Officer Male
Mick Farrell, MBA Chief Executive Officer & Director Male
Peter C. Farrell, PhD,DSc Non-Executive Chairman Male
Carlos M. Nunez, MD Chief Medical Officer Male
Agnes Lee, MBA Senior Director-Investor Relations Female
Frank Lacagnina Chief Information Officer Male
Richie McHale Chief Human Resources Officer Male

Mindful Investing Summary

  • —
  • 1
  • 2
  • 3
  • 4
  • 5
  • Carbon Footprint
    3 N/A
  • Pollution Prevention
    2 N/A
  • Water Conservation
    3 N/A
  • Data & Privacy Protection
    — N/A
  • Consumer Health, Wellness & Safety
    5 N/A
  • Employee Ownership, Satisfaction, Benefits & Pay
    5 N/A
  • Workplace Health and Safety
    3 N/A
  • Integrity of Corporate Governance
    1 N/A
  • Ethical Practices
    — N/A
  • Usage of Conflict Materials
    — N/A
  • Forced Labor
    — N/A
  • Diversity of Corporate Leadership
    2 N/A

ResMed - Competitors and Related Companies

How ResMed stacks up to its peers in the Medical Specialties industry or with competing business segments.

ResMed

RMD:NYS

Medical Specialties

$0
LARGE cap
$156.24 (1.08%)
0.01%
since start of 2020
49.37
  • 3
  • 2
  • 3
  • —
  • 5
  • 5
  • 3
  • 1
  • —
  • —
  • —
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership
  • —
  • 1
  • 2
  • 3
  • 4
  • 5

Royal Philips

PHIA-NL:AMS

Electronic Production Equipment

—
LARGE cap
(—)
—
since start of 2020
—
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • 3
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership
  • —
  • 1
  • 2
  • 3
  • 4
  • 5

Medtronic

MDT:NYS

Medical Specialties

$136.37bn
MEGA cap
$101.75 (2.48%)
-0.11%
since start of 2020
25.69
  • 5
  • 3
  • 5
  • —
  • 2
  • 5
  • 3
  • 1
  • 1
  • —
  • —
  • 3
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership
  • —
  • 1
  • 2
  • 3
  • 4
  • 5

Inogen

INGN:NAS

Medical Specialties

$1.16bn
MID cap
$52.78 (1.72%)
-0.22%
since start of 2020
54.93
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • 5
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership
  • —
  • 1
  • 2
  • 3
  • 4
  • 5

Masimo

MASI:NAS

Medical Specialties

$9.96bn
MID cap
$185.19 (0.01%)
0.17%
since start of 2020
50.44
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • 5
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership
  • —
  • 1
  • 2
  • 3
  • 4
  • 5

Allied Healthcare Products

AHPI:NAS

Medical Specialties

$66.01mm
MICRO cap
$16.45 (-0.70%)
13.02%
since start of 2020
-29.45
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • 5
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership
  • —
  • 1
  • 2
  • 3
  • 4
  • 5